Patents by Inventor Akm Nasir Uddin

Akm Nasir Uddin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PHARMACEUTICAL COMPOSITION OF SEPIAPTERIN
    Publication number: 20250041305
    Abstract: This invention discloses a pharmaceutical composition of sepiapterin with improved processability, stability, and palatability.
    Type: Application
    Filed: September 29, 2022
    Publication date: February 6, 2025
    Inventors: Akm Nasir UDDIN, Mandar Vasant DALI, Dhaval PATEL
  • PHARMACEUTICAL COMPOSITIONS COMPRISING 2,3,5-TRIMETHYL-6-NONYLCYCLOHEXA-2,5-DIENE-1,4-DIONE
    Publication number: 20240000725
    Abstract: Disclosed herein is pharmaceutical compositions of Compound 1, and/or the hydroquinone form thereof, and methods useful for treating or suppressing a disease or disorder such as an ?-synucleinpathy, a tauopathy, an autistic spectrum disorder, a pervasive developmental disorder, a liver disease, and liver damage in a subject using such pharmaceutical compositions.
    Type: Application
    Filed: September 6, 2023
    Publication date: January 4, 2024
    Inventors: Swathi PINNAMANENI, Mandar V. DALI, Dhaval PATEL, Akm Nasir UDDIN
  • TABLET FOR USE IN TREATING HUNTINGTON'S DISEASE AND METHOD OF MAKING THE SAME
    Publication number: 20230405000
    Abstract: The present description relates to a tablet formulation of 2-[3-(2,2,6,6-tetramethylpiperidin-4-yl)-3H-[1,2,3]triazolo[4,5-c]pyridazin-6-yl]-5-(2H-1,2,3-triazol-2-yl)phenol, a compound for use in treating Huntington's disease, and a method of making the same.
    Type: Application
    Filed: November 12, 2021
    Publication date: December 21, 2023
    Inventors: Swathi Pinnamaneni, Akm Nasir Uddin, Mandar Vasant Dali
  • Pharmaceutical compositions comprising 2,3,5-trimethyl-6-nonylcyclohexa-2,5-diene-1,4-dione
    Patent number: 11786486
    Abstract: Disclosed herein is pharmaceutical compositions of Compound 1, and/or the hydroquinone form thereof, and methods useful for treating or suppressing a disease or disorder such as an ?-synucleinpathy, a tauopathy, an autistic spectrum disorder, a pervasive developmental disorder, a liver disease, and liver damage in a subject using such pharmaceutical compositions.
    Type: Grant
    Filed: July 8, 2022
    Date of Patent: October 17, 2023
    Assignee: PTC THERAPEUTICS, INC.
    Inventors: Swathi Pinnamaneni, Mandar V. Dali, Dhaval Patel, Akm Nasir Uddin
  • PHARMACEUTICAL COMPOSITIONS COMPRISING 2,3,5-TRIMETHYL-6-NONYLCYCLOHEXA-2,5-DIENE-1,4-DIONE
    Publication number: 20230022538
    Abstract: Disclosed herein is pharmaceutical compositions of Compound 1, and/or the hydroquinone form thereof, and methods useful for treating or suppressing a disease or disorder such as an ?-synucleinpathy, a tauopathy, an autistic spectrum disorder, a pervasive developmental disorder, a liver disease, and liver damage in a subject using such pharmaceutical compositions.
    Type: Application
    Filed: July 8, 2022
    Publication date: January 26, 2023
    Inventors: Swathi PINNAMANENI, Mandar V. DALI, Dhaval PATEL, Akm Nasir UDDIN
  • COMPOUND FORM HAVING ENHANCED BIOAVAILABILITY AND FORMULATIONS THEREOF
    Publication number: 20220185795
    Abstract: The present description generally relates to amorphous forms of compounds having enhanced aqueous solubility and dissolution rates and amorphous solid dispersions and oral pharmaceutical formulations thereof, and to processes for preparing the same. The present description specifically relates to amorphous forms of 5-fluoro-2-(6-fluoro-2-methyl-1H-benzimidazol-1-yl)-N-[4-(trifluoromethyl)phenyl]pyrimidine-4,6-diamine and amorphous solid dispersions and oral pharmaceutical formulations thereof, and to processes for preparing the same.
    Type: Application
    Filed: March 9, 2020
    Publication date: June 16, 2022
    Inventors: Akm Nasir Uddin, Mandar Vasant Dali, Onkar Shripad Vaze
  • DISPERSIBLE TABLET COMPOSITION
    Publication number: 20220175800
    Abstract: The present description generally relates to a dispersible tablet composition of an active pharmaceutical ingredient (API), which rapidly disperses in water to provide a homogeneous dispersion that ensures uniformity of dose.
    Type: Application
    Filed: April 10, 2020
    Publication date: June 9, 2022
    Inventors: Akm Nasir Uddin, Mandar Vasant Dali
  • BIOAVAILABLE ORAL DOSAGE FORMS
    Publication number: 20210205225
    Abstract: The invention relates to bioavailable pharmaceutical compositions having increased dose loading and improved dissolution less subject to a food effect.
    Type: Application
    Filed: August 2, 2019
    Publication date: July 8, 2021
    Inventors: Mandar V. DALI, Akm Nasir UDDIN
  • VALACYCLOVIR FORMULATIONS
    Publication number: 20090124639
    Abstract: The present invention relates to valacyclovir formulations having improved bioavailability resulting in better efficacy and/or requiring less frequent administration.
    Type: Application
    Filed: November 6, 2008
    Publication date: May 14, 2009
    Applicant: Emisphere Technologies Inc.
    Inventors: Moses Oyewumi, Shingai Majuru, Lewis Bender, Akm Nasir Uddin